FIELD: pharmacology.
SUBSTANCE: invention relates to the new quaternary ammonium salts of 2-aminothiophene-3-carboxylic acid derivatives having anti-tuberculosis activity of general formula I
and formula II
where X is absent or is -CH2-, -(CH2)2-, CH3CH-, -N(R4)-; R1 is CN, C(O)OR5, C(O)NHR6; R4 are aliphatic saturated, unbranched or branched C1-C5 hydrocarbon, benzyl; R5 are aliphatic saturated, unbranched or branched C1-C5 hydrocarbon; R6 are H, aliphatic saturated, unbranched or branched C1-C5 hydrocarbons, cyclic hydrocarbons C3-C7.
EFFECT: increased efficiency.
2 cl, 2 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2435763C2 |
| SUBSTITUTED AZOLO[1,2,4,5]TETRAZINES - INHIBITORS OF ANTIBACTERIAL SERINE-THREONINE PROTEIN KINASES | 2011 |
|
RU2462466C1 |
| COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARISATION AND RELATED DISEASES | 2011 |
|
RU2600794C2 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTION OF METASTATIC CANCER CELLS | 2010 |
|
RU2519123C2 |
| FURILIDENE FURANONE DERIVATIVES OF USNIC ACID AS NEW ANTITUBERCULOSIS AGENTS | 2013 |
|
RU2533707C1 |
| OLIGOGLYCOL-CARBONATE PRODRUGS BASED ON 5-MODIFIED 2'-DEOXYURIDINES EXHIBITING ANTIBACTERIAL ACTIVITY | 2022 |
|
RU2808726C1 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
| THIAZOLINO-2-PYRIDONES WITH CONDENSED RINGS IN COMBINATION WITH A DRUG AGAINST TUBERCULOSIS | 2018 |
|
RU2791467C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
| METHOD FOR PRODUCING AN ACETYLCHOLINESTERASE (AChE) INHIBITOR AND INHIBITOR PRODUCED BY THE METHOD | 2021 |
|
RU2779555C1 |
